テクニカル掲示板

Breaking News
Coronavirus – How it began
During the beginning of this year, a novel coronavirus disease — termed Covid-19 by the WHO — was identified as being responsible for a sudden increase in cases of pneumonia in hospitalized patients. We have seen this rapidly escalate into a global... さらに読む ›
Research Trend
A new scar reduction role for engineered T cells
Cardiovascular diseases (CVDs) are the number one cause of death globally, responsible for 31% of all human mortalities. This is in part due to lifestyle but also because the human heart is incapable of functional regeneration following injury or on... さらに読む ›
Interesting Story
The painless people
Wouldn’t it be nice if we felt no pain? Although lacking the ability to feel pain sounds tempting, considering we could have simply moved on with our lives without going through the hassle of tending to our injuries, the consequences of being painle... さらに読む ›
Research Trend
De-arming CRISPR/Cas9 to increase knock-in efficiency
The ability to knock in (KI) DNA sequences via homologous recombination (HR) to generate knockout (KO) mice was first demonstrated 30 years ago by Mario R. Capecchi, Martin J. Evans and Oliver Smithies (1,2). In recent years, CRISPR/Cas9 has revolut... さらに読む ›
Latest Discovery
From Fibroblast to Blastocyst: The magic ingredients
When the lab of Shinya Yamanaka revealed that viral introduction of Oct3/4, Sox2, Klf4 and c-Myc (OSKM) into adult skin cells could transform them into induced pluripotent stem cells (iPSCs), the world quickly took notice at the prospect of using iP... さらに読む ›
Research Trend
CRISPRing our cellular roots
The remarkable process by which a single totipotent zygote develops into the approximately 37 trillion cells in a human body is orchestrated by a highly controlled sequence of signaling events resulting in a multitude of differentiated cell types. T... さらに読む ›
Research Trend
AAVs usher in the new era of Gene Therapy
Adeno-associated virus (AAV), initially discovered as a contaminant of adenovirus preparations (1), is the choice vehicle for gene therapy due to its ability to transduce proliferating and non-dividing cells with no known pathogenicity to humans. As... さらに読む ›
Research Trend
AAV – The king of viral vectors?
Adeno-associated virus (AAV) has recently been surging in popularity as a vector system. The recent wave of gene therapy successes and powerful new genome editing technologies, such as CRISPR/Cas9, have increased public and scientific awareness of t... さらに読む ›
Research Trend
Vectors on the brain
The nervous system presents several unique challenges that make it a difficult system to study experimentally. At a structural level, the brain has a complexity that is orders of magnitude greater than other organs, and even the peripheral nervous s... さらに読む ›
Research Trend
Optogenetics in the clinic
Ever since the cloning of channelrhodopsin-2 (ChR2), there has been an explosion of interest in applying optogenetic methods to all aspects of neuroscience1. Initially, ChR2 was used to control neuronal activity in vitro2,3, and shortly thereafter in... さらに読む ›
Research Trend
Lentivirus “cure” for a ALD
For decades, new innovations in stem cell biology and genetic manipulation have driven a wave of proposed treatments based on these technologies. Although there has been intense speculation and expectation about when and how these methods will final... さらに読む ›
Latest Discovery
Treating alcoholism with gene therapy
Alcoholism is a complex disease affecting hundreds of millions of people worldwide1. Despite having devastating consequences on physical and mental health, and indirectly impacting families and society, treatment options are limited and often ineffec... さらに読む ›
Research Trend
In vivo reprogramming with viral vectors
Although multicellular organisms are made up of many cell types, all with essentially identical genomes, cells rarely interconvert between cell types. Once a cell acquires a specific cell fate, it generally does not assume the phenotype of an alternate cell type.... さらに読む ›
Research Trend
shRNA screens lead to major discoveries
Loss-of-function screening using shRNA libraries is a powerful way to identify genes involved in almost any biological process. Over the past decade, shRNA screens, both in vivo and in cell culture systems, have generated many important discoveries... さらに読む ›
Research Trend
Controlling when and where: Conditional and inducible gene expression
In the early days of engineered animal models, simple knockout and transgenic mice were used to examine gene function. Researchers began to dissect the roles of individual genes by studying phenotypes of mice lacking or overexpressing specific genes... さらに読む ›
様々なクローニングのご注文は、ホームページ上の次 ベクターをデザインする または デザインリクエスト を送る からできます。また以下のメニューバーをお使いください。 受託サービスと製品
弊社の最新テクノロジーのご質問は、次までご連絡ください。 フィードバックを 残す または コンタクト.